What We Do: GPCR, Qunatum & Internal Neurocomputational Medicine Lab
Our research is on hybrid deep learning network’s ai application, in event analysis for inhibiting using GPCR signaling via ligand EGF (epidermal growth factor) for Mitogen activated protein kinase(enzyme) MAPK/ extra cellular signal regulated protein kinase (ERK) , which takes a high energy phosphate such as ATP or GTP and transforms into molecules while leveraging the energy in transformation to cause mechanism for a biological event initiation via Second messagner (cAMP), either replication or other metabolic mechanism that produce blood cancer.
cAMP is a derivative of adenosine triphosphate (ATP) which is used for intracellular signal transduction. that conveys A cAMP-dependent pathway. We leverage this as our main pipeline research
In that pathway analysis our research is to investigate blood cell DNA growth restriction on replication (mitosis) for Blood cells causing blood disease or cancer resulting from Severe Amenia, Congenital or Toxic - inherited or C0 exposed blood toxicity.
Who We are: Center For Preventative Medicine & Control:
Confidential, Ai Development Lab In Public and Primary Healthcare. -Blood &
Brain Disease Research Center
Research Laboratory For Brain and Bacterial Meningitis
Research Laboratory For Diabetes and CKD
Centre For Blood Research and Genomic /inherited Blood Disease Research
Centre for Exta-Pathological Collaboration- Inter industry Data Share
Note: A3iNet is a hybrid Deep Learning HDNN, Neural Network Systems, applied to Complex Systems Of Systems' Scientific and Industrial Systems Integration as Solution enforced with Ai for Large Scale Enterprise Integration, LSSI, developed by Swedish World Wide & Aerovition Digital Inc..
Application of ML, Ai Research in Bio Medical Engineering, Case Study Analysis:
Suffering From Any Of The Following Cases,? ASK your webdaktar For Diagnostics
Cases -Primary Healthcare Diagnostics , - A Solution For Print Disable Patients
Research & Development - Liver Cancer, TF, Blood Cell count and Activation Status for B , T, NK -Lymphocyte
Amsterdam, The Hague, Netherlands | European Union | Vancouver, Toronto, ON, Canada | Santa Clara, CA USA | Paris, France | Oxfordshire, Cambridgeshire, London, United Kingdom | African Union Countries | Singapore, SG | Japan | South East Asian Countries | NZ & Australia | Developing World Countries Of Asia, Africa, Latin America, and Asia.